The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury
Open accessAbstract
Emerging metabolomic tools have created the opportunity to establish metabolic signatures of myocardial injury. We applied a mass spectrometry-based metabolite profiling platform to 36 patients undergoing alcohol septal ablation treatment for hypertrophic obstructive cardiomyopathy, a human model of planned myocardial infarction (PMI). Serial blood samples were obtained before and at various intervals after PMI, with patients undergoing elective diagnostic coronary angiography and patients with spontaneous myocardial infarction (SMI) serving as negative and positive controls, respectively. We identified changes in circulating levels of metabolites participating in pyrimidine metabolism, the tricarboxylic acid cycle and its upstream contributors, and the pentose phosphate pathway. Alterations in levels of multiple metabolites were detected as early as 10 minutes after PMI in an initial derivation group and were validated in a second, independent group of PMI patients. A PMI-derived metabolic signature consisting of aconitic acid, hypoxanthine, trimethylamine N-oxide, and threonine differentiated patients with SMI from those undergoing diagnostic coronary angiography with high accuracy, and coronary sinus sampling distinguished cardiac-derived from peripheral metabolic changes. Our results identify a role for metabolic profiling in the early detection of myocardial injury and suggest that similar approaches may be used for detection or prediction of other disease states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Physiological concentrations of purines and pyrimidines
Traut, T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928361 · Cited by 1,867
Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
Nicholson, J. K., & Wilson, I. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1157 · Cited by 1,116
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations
Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M. C., Berden, J. A., Brindle, K. M., Kell, D. B., Rowland, J. J., et al. (2001) · Nature Biotechnology · doi:10.1038/83496 · Cited by 1,005
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
Sigwart, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91267-3 · Cited by 800
High-throughput classification of yeast mutants for functional genomics using metabolic footprinting
Allen, J., Davey, H. M., Broadhurst, D., Heald, J. K., Rowland, J. J., Oliver, S. G., & Kell, D. B. (2003) · Nature Biotechnology · doi:10.1038/nbt823 · Cited by 538
Rules of evidence for cancer molecular-marker discovery and validation
Ransohoff, D. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1322 · Cited by 498
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., & Gerszten, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.569137 · Cited by 461
Self-citationAn, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Matsui, T., Li, L., del Monte, F., Fukui, Y., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (1999) · Circulation · doi:10.1161/01.cir.100.23.2373 · Cited by 383
Self-citationLC/MS applications in drug development
Lee, M. S., & Kerns, E. H. (1999) · Mass Spectrometry Reviews · doi:10.1002/(sici)1098-2787(1999)18:3/4<187::aid-mas2>3.0.co;2-k · Cited by 339
Knight, C., Kurbaan, A. S., Seggewiss, H., Henein, M., Gunning, M., Harrington, D., Fassbender, D., Gleichmann, U., & Sigwart, U. (1997) · Circulation · doi:10.1161/01.cir.95.8.2075 · Cited by 300
Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial Infarction
Zimmerman, J., Fromm, R., Meyer, D., Boudreaux, A., Wun, C.-C. C., Smalling, R., Davis, B., Habib, G., & Roberts, R. (1999) · Circulation · doi:10.1161/01.cir.99.13.1671 · Cited by 295
Roberts, R., Gowda, K. S., Ludbrook, P. A., & Sobel, B. E. (1975) · The American Journal of Cardiology · doi:10.1016/0002-9149(75)90890-5 · Cited by 276
Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy
Lakkis, N. M., Nagueh, S. F., Kleiman, N. S., Killip, D., He, Z.-X., Verani, M. S., Roberts, R., & Spencer, W. H. (1998) · Circulation · doi:10.1161/01.cir.98.17.1750 · Cited by 230
Substrate Control of Free Radical Generation from Xanthine Oxidase in the Postischemic Heart
Xia, Y., & Zweier, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18797 · Cited by 229
LC/MS applications in drug development.
Lee, M. S., & Kerns, E. H. (1999) · PubMed · Cited by 207
Immune activation and degradation of tryptophan in coronary heart disease
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., & Fuchs, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01186.x · Cited by 190
Proton NMR analysis of plasma is a weak predictor of coronary artery disease
Kirschenlohr, H. L., Griffin, J. L., Clarke, S. C., Rhydwen, R., Grace, A. A., Schofield, P. M., Brindle, K. M., & Metcalfe, J. C. (2006) · Nature Medicine · doi:10.1038/nm1432 · Cited by 177
Alterations of myocardial amino acid metabolism in chronic ischemic heart disease.
Mudge, G. H., Mills, R. M., Taegtmeyer, H., Gorlin, R., & Lesch, M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108571 · Cited by 164
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up
Lakkis, N. M., Nagueh, S. F., Dunn, J. K., Killip, D., & Spencer, W. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00767-1 · Cited by 154
High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies
Wevers, R. A., Engelke, U. F. H., & Heerschap, A. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.7.1245 · Cited by 129
Yoerger, D. M., Picard, M. H., Palacios, I. F., Vlahakes, G. J., Lowry, P. A., & Fifer, M. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.040 · Cited by 89
Self-citationNormal plasma free amino acid values in adults: The influence of some common physiological variables
Scriver, C. R., Gregory, D. M., Sovetts, D., & Tissenbaum, G. (1985) · Metabolism · doi:10.1016/0026-0495(85)90112-x · Cited by 88
The Search for a Biomarker of Cardiac Ischemia
Morrow, D. A., de Lemos, J. A., Sabatine, M. S., & Antman, E. M. (2003) · Clinical Chemistry · doi:10.1373/49.4.537 · Cited by 83
Self-citationPathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Baggish, A. L., Smith, R. N., Palacios, I. F., Vlahakes, G. J., Yoerger, D. M., Picard, M. H., Lowry, P. A., Jang, I.-K., & Fifer, M. A. (2006) · Heart · doi:10.1136/hrt.2006.092007 · Cited by 65
Self-citationBeecher, C. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0333-0_17 · Cited by 55
Keyzer, J. J., Breukelman, H., Wolthers, B. G., Richardson, F. J., & de Monchy, J. G. R. (1985) · Inflammation Research · doi:10.1007/bf01983105 · Cited by 45
Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion
Bäckström, T., Goiny, M., Lockowandt, U., Liška, J., & Franco‐Cereceda, A. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00138.2002 · Cited by 45
Extracellular Amino Acids as Markers of Myocardial Ischemia during Cardioplegic Heart Arrest
Kennergren, C. E. H., Mantovani, V., Lönnroth, P., Nyström, B., Berglin, E., & Hamberger, A. (1999) · Cardiology · doi:10.1159/000006874 · Cited by 32
Urinary hypoxanthine and xanthine levels in acute coronary syndromes
Turgan, N., Habif, S., Gülter, C., Şenol, B., MUTAF, I., Özmen, D., Bayındır, O., Boydak, B., & Turgan, N. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050084 · Cited by 31
Myocardial ischemia induces coronary t‐PA release in the pig
Österlund, B., Andersson, B., Häggmark, S., Jern, C., JOHANSSON, G., Seeman-Lodding, H., & Biber, B. (2002) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2002.t01-1-460308.x · Cited by 30
Interstitial purine metabolites during regional myocardial ischemia
Dorheim, T. A., Wang, T., Mentzer, R. M., & Wylen, D. G. L. (1990) · Journal of Surgical Research · doi:10.1016/0022-4804(90)90019-x · Cited by 30
Extremity amino acid metabolism during starvation and intravenous refeeding in humans
Albert, J. D., Legaspi, A., Horowitz, G. D., Tracey, K. J., Brennan, M. F., & Lowry, S. F. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.5.e604 · Cited by 22
Srinivasan, K. N., Pugalendi, K. V., Sambandam, G., Rao, M. R., Krishnan, S., & Menon, V. P. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00071-0 · Cited by 8
Cited by
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R. E., Vadysirisack, D. D., Guimaraes, A., Marinelli, B., Wikstrom, J. D., Nir, T., et al. (2010) · Cell · doi:10.1016/j.cell.2009.12.041 · Cited by 1,001
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011) · Chem. Soc. Rev. · doi:10.1039/b906712b · Cited by 860
Dzeja, P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 475
‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics
Horgan, R. P., & Kenny, L. C. (2011) · The Obstetrician & Gynaecologist · doi:10.1576/toag.13.3.189.27672 · Cited by 456
Metabolic signatures of exercise in human plasma
Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001006 · Cited by 432
Self-citation
Metadata
- Authors
- Lewis, G. D., Wei, R., Liu, E., Yang, E., Shi, X., Martinovic, M., Farrell, L., Asnani, A., Cyrille, M., Ramanathan, A., Shaham, O., Berriz, G., Lowry, P. A., Palacios, I. F., Ta_an, M., Roth, F. P., Min, J., Baumgartner, C., Keshishian, H., Addona, T., Mootha, V. K., Rosenzweig, A., Carr, S. A., Fifer, M. A., Sabatine, M. S., & Gerszten, R. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-10-01
- Volume
- 118
- Issue
- 10
- Pages
- 3503-3512
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2099694349
- Cited by
- 283
- References
- 39
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.